Morgan_Stanley-Global_Equity_Strategy_Launching_Global_Best_Business_Model...-112827612_129页_9mb

Summary of Morgan Stanley Global Best Business Models (BBM) Version 5

This report by Morgan Stanley identifies 31 high-quality companies selected for a two-year buy-and-hold investment strategy focused on long-term alpha generation. The selection process involves a systematic approach, combining quantitative quality and value assessments with qualitative inputs from fundamental analysts and ESG evaluations.

Key Points:

• Selection Methodology: The process includes a two-stage quality and value screen, industry-specific fundamental analysis, and final assessment by analyst teams to ensure a diversified portfolio with sustainable competitive advantages.
• Performance: These stocks deliver a 40% premium in trailing ROE and a 17% premium in forward P/E compared to the MSCI ACWI benchmark. Cumulative outperformance since the framework's inception in 2016 is approximately 440 basis points.
• Regional Distribution: Companies are allocated as follows: North America (12), Europe (7), Asia-Pacific/EM (8), and Japan (4). Valuation and fundamentals were adjusted due to current market conditions.
• Quality Framework: Assessment includes profitability (e.g., ROE, RNOA, accruals), capital use, balance sheet risks, and valuation metrics (e.g., FCF yield, EV/EBITDA). Banks, insurance, and diversified financials use adapted criteria.
• Key Competitive Advantages: Companies like Apple leverage ecosystems, Boston Scientific excels in niche medical devices, and Eli Lilly benefits from GLP-1 drug growth. Competitive advantages stem from quality, pricing power, and sustainable business models.
• Risks: Portfolio risks include valuation shifts, competitive pressures, regulatory changes, and execution risks. Morgan Stanley addresses these through rigorous assessments.

Overall, the BBM framework targets superior returns by focusing on quality and sustainability, with detailed analysis provided for each company to support informed investment decisions without conflicts of interest.